As research into HPV continued, scientists began to uncover the astonishing diversity of this virus family. In the 1980s, German virologist Harald zur Hausen made a groundbreaking discovery: he identified HPV types 16 and 18 as the primary culprits behind cervical cancer. This finding revolutionized our understanding of HPV and paved the way for the development of HPV vaccines.
Today, we know that there are over 200 types of HPV, each designated with a unique number. While most HPV types are harmless and resolve on their own, about 40 types can infect the genital area and potentially lead to health issues.
HPV types are generally categorised into two groups:
1. Low-risk HPV types, such as HPV 6 and 11, which can cause genital warts but rarely lead to cancer.
2. High-risk HPV types, like HPV 16, 18, 31, 33, and 45, which are associated with various cancers, including cervical, anal, and oropharyngeal cancers.
This knowledge has been crucial in guiding screening, prevention, and treatment strategies for HPV-related conditions.
Something that has been missing in the conventional medical approach to the treatment of HPV-related conditions is the role of the immune system in clearing HPV. In my own healing journey I found that 90% of people clear HPV naturally within the first two years. This led me to ask what was different about the 10% in whom HPV persists and potentially lead to more severe downstream health problems. When I emerged from the rabbit hole I had devised an approach for understanding HPV from a holistic point of view and actionable steps to help the immune system to be at its best to clear HPV in this group of people. And it worked!